Drugs / INDV-6001
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06576843 | Sep 2024 → Jan 2026 | opiate dependence | Indivior Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INDV-6001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06576843 ↗ |
| Route | Subcutaneous | “Extended-release subcutaneous injection” NCT06576843 ↗ |